Dennis Purcell

Contact Dennis

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm that invests in products, technologies, and global businesses across the Life Sciences industry.  Aisling Capital has raised over $1.8 billion since inception.

Prior to founding Aisling Capital, Mr. Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase Hambrecht & Quist, where he supervised over $10 billion of financing and advisory assignments in the pharmaceutical, biotechnology, and medical products industries. Previously, Mr. Purcell was a Managing Director in the Healthcare Group at PaineWebber, Inc.

Dennis is a frequent commentator on the industry and is actively involved with many of the industry’s professional organizations. He has been a member of the board of numerous private and public healthcare companies and currently serves as Executive Chairman of Poliwogg Holdings.  He sits on the board of Summus Global, Inc., Life Science Leader Magazine –Editorial Advisory Board, NY BIO Association, and the NY Investment Fund, as well as a Senior Industry Advisor for Bioscience Managers Pty Ltd.  Mr. Purcell is a member of The University of Delaware Investment Committee, Harvard Kennedy School – M-R CBG Advisory Council, and the New York Leadership Council.

He received his MBA from Harvard University and his BS in Accounting from the University of Delaware.

Our Team

Norman Selby

Executive Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles...

read full biography >

Roger Longman

Chief Executive Officer

Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key...

read full biography >

Susan Raiola


Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Jane F. Barlow, MD

EVP & Chief Clinical Officer

Before starting her own firm, Dr. Barlow served as Associate Chief Medical Officer for CVS Health...

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Laura Farmer

SVP, Business Development and Marketing

Laura Farmer leads business development and marketing for Real Endpoints and subsidiary, Reimbursement Intelligence...

read full biography >

Jane Borne, RPh

VP, Pharmacy

Jane Borne, RPh, is responsible for ensuring the clinical credibility and evidence basis of all RE drug evaluation activities...

read full biography >

Heather Ritchie

VP, Product Strategy and Development

Heather Ritchie is VP Product Strategy and Development at Real Endpoints. She works closely with our customers and partners...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art founded Pappas Capital in 1994, and over the past two decades the firm has managed more than $535 million in capital...

read full biography >